CeriBell, Inc. (CBLL) Gross Margin
- Gross margin · 12 months: Value 88.90%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 88.90% | Gross profit / revenue. Period ending 2026-06-30. $90.64M ÷ $101.96M × 100 ≈ 88.90% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 90.64M USD | Gross Profit |
| Revenue | 101.96M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $90.64M | $101.96M | (m) | 88.90% |
| 2026-03-31 | $83.39M | $95.07M | (m) | 87.72% |
| 2025-12-31 | $78.27M | $89.06M | (m) | 87.89% |
| 2025-09-30 | $72.87M | $82.81M | (m) | 87.99% |
| 2025-06-30 | $67.94M | $77.42M | (m) | 87.75% |
| 2025-03-31 | $62.41M | $71.53M | (m) | 87.25% |
| 2024-12-31 | $56.75M | $65.44M | (m) | 86.72% |
| 2024-09-30 | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) |
| 2023-12-31 | $38.16M | $45.23M | (m) | 84.38% |
| 2023-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |